ACLIPSE THERAPEUTICS
Aclipse Therapeutics is a biopharmaceutical company that focuses on developing differentiated drugs to address diseases with unmet medical needs. Its strategy is reducing clinical development risk by combining a new and druggable understanding of disease pathways with a novel drug molecule that inhibits these pathways, allowing us to build upon existing nonclinical and clinical data while creating a significant patent barrier-to-entry.
ACLIPSE THERAPEUTICS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2017-01-01
Address:
Radnor, Pennsylvania, United States
Country:
United States
Website Url:
http://www.aclipsetherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
5.57 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Panoptes Pharma
Developing innovative small molecule drugs to treat eye diseases with high unmet medical need.
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Current Employees Featured
Raymond K. Houck President & CEO @ Aclipse Therapeutics
President & CEO
Ning Shan CSO @ Aclipse Therapeutics
CSO
Founder
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Aclipse Therapeutics
Medical Research Council
Medical Research Council investment in Grant - Aclipse Therapeutics
FightMND
FightMND investment in Grant - Aclipse Therapeutics
Intellectual Digital Global (iDG)
Intellectual Digital Global (iDG) investment in Series A - Aclipse Therapeutics
Intellectual Digital Corp. (iDC)
Intellectual Digital Corp. (iDC) investment in Seed Round - Aclipse Therapeutics
Official Site Inspections
http://www.aclipsetherapeutics.com Semrush global rank: 5.91 M Semrush visits lastest month: 1.4 K
- Host name: 151.101.194.159
- IP address: 151.101.194.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aclipse Therapeutics"
Aclipse Therapeutics - Crunchbase Company Profile & Funding
Contact Email info@aclipsetherapeutics.com Aclipse Therapeutics is a biopharmaceutical company that focuses on developing differentiated drugs to address diseases with unmet …See details»
Aclipse Therapeutics LLC - Drug pipelines, Patents, Clinical trials ...
Explore Aclipse Therapeutics LLC with its drug pipeline, therapeutic area, technology platform, 2 news, Disease Domain:Nervous System Diseases, Endocrinology and Metabolic Disease, …See details»
Aclipse Therapeutics - LinkedIn
Aclipse Therapeutics is focused on developing novel and highly differentiated drugs to address diseases with high unmet medical needs. Our strategy is reducing clinical development risk by ...See details»
Therapeutics - Aclipse Therapeutics
Therapeutics for Challenging Diseases M107 M102 Pipeline Indications for M102 We’re here to answer any questions. Looking to connect with us? CONTACT USSee details»
Aclipse Therapeutics - Overview, News & Similar companies
Apr 20, 2022 Aclipse Therapeutics contact info: Phone number: (412) 606-7214 Website: www.aclipsetherapeutics.com What does Aclipse Therapeutics do? Aclipse Therapeutics is an …See details»
Aclipse Therapeutics LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Aclipse Therapeutics LLC of King OF Prussia, PA. Get the latest business insights from Dun & …See details»
Press Release Archives - Aclipse Therapeutics
Nov 10, 2024 For more information about Aclipse Therapeutics, visit the website at https://www.aclipsetherapeutics.com or email info@aclipsetherapeutics.com. Contacts …See details»
Aclipse Therapeutics Company Profile | Management and
Smith@aclipsetherapeutics.com: Aclipse Therapeutics Top Competitors. Company Employees Revenue Top technologies; Collaborative Medicinal Development LLC. 10: $4.4 M: CuraSen …See details»
Aclipse Therapeutics | Raymond K. Houck | Treatment for ...
Www.aclipsetherapeutics.com. Contact: Raymond K. Houck, CEO. Aclipse Therapeutics. 170 N. Radnor Chester Rd., Suite 350. Radnor, PA 19087 USA ... One needs to understand the …See details»
Aclipse Therapeutics Announces Publication in Nature …
Jan 2, 2023 Aclipse has an experienced drug development team and a clinical advisory board of key opinion leaders in ALS. For more information about Aclipse Therapeutics, visit the website at https://www.aclipsetherapeutics.com or …See details»
Aclipse Therapeutics - Products, Competitors, Financials, …
Aclipse Therapeutics is a company that focuses on the development of novel and highly differentiated therapeutics, operating within the pharmaceutical industry. Use the CB Insights …See details»
Aclipse Therapeutics - Craft
Aclipse Therapeutics has 5 employees at their 1 location and $1 m in total funding,. See insights on Aclipse Therapeutics including office locations, competitors, revenue, financials, …See details»
Aclipse Therapeutics Announces $2.2 Million Grant from UK’s …
Jan 26, 2021 For more information about Aclipse, visit the website at https://www.aclipsetherapeutics.com or email info@aclipsetherapeutics.com. Contacts …See details»
Aclipse Therapeutics Announces $1.475 Million Award from the US ...
Apr 20, 2022 Raymond K. Houck rhouck@aclipsetherapeutics.com +1-412-606-7214 Release Summary Aclipse Therapeutics Announces $1.475M Award from the U.S. Department of …See details»
Aclipse Therapeutics Expands Drug Development Pipeline
Sep 14, 2023 rhouck@aclipsetherapeutics.com +1-412-606-7214. Prev Aclipse Therapeutics Announces Publication in Nature Reviews Drug Discovery of an Amyotrophic Lateral Sclerosis …See details»
Aclipse Therapeutics Expands Drug Development Pipeline with …
Sep 14, 2023 Raymond K. Houck rhouck@aclipsetherapeutics.com +1-412-606-7214 Site Navigation. Home. Home; Submit a Press Release; Services; News. All News; News with …See details»
News + Press - Aclipse Therapeutics
Jul 18, 2022 KING OF PRUSSIA, Penn.–(BUSINESS WIRE)–Aclipse Therapeutics LLC (“Aclipse” or “the Company”) today announced that its M102 drug development program has …See details»
Aclipse Therapeutics Awarded AUD 1 Million Grant from FightMND
Sep 29, 2020 Raymond K. Houck rhouck@aclipsetherapeutics.com +1-412-606-7214 Release Summary. Aclipse Therapeutics awarded a $720,000 drug development grant from FightMND …See details»
Science - Aclipse Therapeutics
Innovative Approach to Treat Diseases with High Unmet Needs Disease Focus Aclipse focuses on neuromuscular diseases that are strongly impacted by molecular pathways that regulate …See details»